Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET
Company Participants
Andrea Flynn - VP & Head, IR
Bruce Cozadd - Co-Founder, Chairman & CEO
Daniel Swisher - President & COO
Robert Iannone - EVP & Global Head, Research & Development
Renee Gala - EVP & CFO
Kim Sablich - EVP & GM, US
Conference Call Participants
Marc Goodman - SVB Securities
Jason Gerberry - Bank of America Merrill Lynch
Joseph Thome - TD Cowen
Jeff Hung - Morgan Stanley
Gregory Fraser - Truist Securities
Balaji Prasad - Barclays Bank
Ashwani Verma - UBS
Brandon Folkes - Cantor Fitzgerald & Co.
Ami Fadia - Needham & Company
David Amsellem - Piper Sandler & Co.
Gregory Renza - RBC Capital Markets
Madhu Kumar - Goldman Sachs Group
Operator
Good day, and thank you for standing by. Welcome to the Q1 2023 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Andrea Flynn, Vice President and Head of Investor Relations. Please go ahead.
Andrea Flynn
Thank you, operator, and good afternoon, everyone. Today, Jazz Pharmaceuticals reported its first quarter 2023 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted to our website. On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renee Gala, Executive Vice President and Chief Financial Officer; Dan Swisher, President and Chief Operating Officer; and Rob Iannone, Executive President, Global Head of R&D; Kim Sablich, Executive Vice President and General Manager of United States, will join the team for Q&A.
On Slide 2, I'd like to remind you that today's webcast includes forward-looking statements, such as those related to our future financial and operating results, growth potential and anticipated development and commercialization milestones and goals, which involve risks and uncertainties that could cause actual events, performance and results to differ materially from those contained in these forward-looking statements.
We urge you to review the statements contained in today's press release, in our slide deck and in our latest SEC disclosure documents, which identify certain factors that may cause the company's actual events, performance and results to differ materially from those contained in these forward-looking statements made on today's webcast. We undertake no obligation to update our forward-looking statements.